K-V Pharma seeks Chapter 11 bankruptcy protection - Sacramento Bee

08/06/12

K-V Pharma seeks Chapter 11 bankruptcy protection
Sacramento Bee
NEW YORK -- K-V Pharmaceutical Co. is filing for Chapter 11 bankruptcy protection as it deals with weak sales, a payment related to its costly preterm birth drug Makena and sanctions related to past manufacturing problems. The St. Louis company's ...

[more]